ESG-401 – Interleukin Related interleukin-related.com

Product Name :
ESG-401

Search keywords :
SN-38

drugId :
null

Target Vo:
Tumor-associated calcium signal transducer 2

Target Vo Short Name :
Trop-2

Moa_Name:
Anti-Trop-2

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Escugen Biotechnology Co Ltd

Active Company_Name :
Shanghai Escugen Biotechnology Co Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PUMA Antibody
GLUT2 Antibody
Phospho-c-Jun (Ser73) Antibody: Phospho-c-Jun (Ser73) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser73). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts